Cafepharma Today

March 10 2025 - On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Novo Nordisk's Ozempic successor disappointed Wall Street again
AstraZeneca reports positive outcomes from trial of Imfinzi
The evolution of medical sales: what’s changing in 2025?
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Scientists Build a Case for Banning Viagra From Sports
WSJ Online
Monday, November 24, 2008 - 10:12am
tags:
Pharma Updates And What You Need To Know
CNBC
Monday, November 24, 2008 - 10:08am
tags:
Exelixis gets $20 million milestone payment as Bristol-Myers Squibb develops cancer drug
Yahoo/AP
Monday, November 24, 2008 - 10:08am
tags:
J&J to Acquire Omrix for $438 Million
TheStreet.com
Monday, November 24, 2008 - 10:07am
tags:
Sanofi Gains After Morgan Stanley Raises Rating, Price Estimate
Bloomberg
Monday, November 24, 2008 - 10:06am
tags:
Biotech Companies Strapped for Cash in Weak Economy
WSJ Online
Monday, November 24, 2008 - 10:03am
tags:
NicOx Jumps to Six-Month High on Naproxcinod Results
Bloomberg
Monday, November 24, 2008 - 10:00am
tags:
Alpharma Accepts King’s $1.6 Billion Takeover Offer
Bloomberg
Monday, November 24, 2008 - 9:32am
tags:
Alnylam sees results for liver disease treatment
bizjournals.com
Saturday, November 22, 2008 - 11:55am
tags:
Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh- immunization Prevention Project
PR Canada.net
Saturday, November 22, 2008 - 11:54am
tags:
Salix Setback Keeps It a Sell
Trading Markets
Saturday, November 22, 2008 - 11:52am
tags:
Indian biotech industry expected to grow despite global meltdown
Newstrack India, India
Saturday, November 22, 2008 - 11:32am
tags:
Valdoxan(R), the First Melatonergic Antidepressant, Receives EU CHMPPositive Opinion for Major Depressive Disorder
CNW Telbec, Canada
Saturday, November 22, 2008 - 11:30am
tags:
Johnson & Johnson gets FDA approval for pain drug
Yahoo/AP
Saturday, November 22, 2008 - 11:01am
tags:
The Comeback of the Century? (AstraZeneca and Iressa)
Motley Fool
Saturday, November 22, 2008 - 11:00am
tags:
Oppenheimer takes cautious view on ViroPharma
Yahoo/AP
Saturday, November 22, 2008 - 10:58am
tags:
Barr Shareholders Approve Pending Teva Acquisition
PR NewsWire
Saturday, November 22, 2008 - 10:56am
tags:
Jazz Phamarceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
Pipeline Review
Saturday, November 22, 2008 - 10:55am
tags:
Glenmark receives approval for Ranitidine Tablets USP from the U.S. FDA
Pipeline Review
Saturday, November 22, 2008 - 10:54am
tags:
FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
PR NewsWire
Saturday, November 22, 2008 - 10:35am
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

Bridging the Gap in Patient Support: How GoodRx is Revolutionizing Access to Specialty Meds
Drug Channels
Bird is the (Geomagnetic) Word
In the Pipeline
The Continuing Crisis, Part VII: An Overview
In the Pipeline
Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws
Drug Channels
The Continuing Crisis, Part VI: Rare Diseases at the FDA and More
In the Pipeline
PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)
Drug Channels
Progress on RNA-Based Cancer Vaccines
In the Pipeline
Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information